Brokerages Set Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Price Target at $12.38
Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) have been given an average recommendation of “Buy” by the five analysts that are presently covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) have been given an average recommendation of “Buy” by the five analysts that are presently covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
